Review



mesenchymal stem cells asc  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC mesenchymal stem cells asc
    Mesenchymal Stem Cells Asc, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 515 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/normal+human+asc/Adipose-Derived+Mesenchymal+Stem+Cells%3B+Normal%2C+Human/pm36626752-176-1-5
    Average 96 stars, based on 515 article reviews
    mesenchymal stem cells asc - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    In Vitro:

    Article Title: SiO2 and ZnO nanostructures embedded gum Arabic-based edible coating improves shelf-life of barhi dates
    Article Snippet: The fabricated materials morphological properties were studied with a scanning electron microscope (JEOL, Japan). .. The hMSCs (human mesenchymal stem cells) cell line acquired from ATCC, USA, was employed as in vitro model in this study. .. DMEM (Dulbecco's Modified Eagle Medium), with fetal bovine serum (10%) and streptomycin/penicillin mixture (1%), was used to grow the cells.

    Concentration Assay:

    Article Title: Hierarchical stabilization of bioactive hydrogels by multi-arm peptide-polymer supramolecular staples.
    Article Snippet: .. Adipose-derived stem cells (ADSCs; ATCC PCS-500-011) were introduced into the hydrogel systems at a final concentration of 5 105 cells mL 1 for morphometric analysis. .. Adipose-derived stem cells (ADSCs; ATCC PCS-500-011) were introduced into the hydrogel systems at a final concentration of 5 105 cells mL 1 for morphometric analysis.

    Cell Culture:

    Article Title: High-Resolution 3D Bioprinted Hydrogel Scaffolds Enable Sustained Intraperitoneal Cell Delivery.
    Article Snippet: Gibco), hereby referred to as standard culture medium. .. Adipose-derived human mesenchymal stem cells (hMSC, PCS-500-011) were purchased from ATCC (Manassas, VA, USA). hMSC cells were cultured in Dulbecco’s Modified Eagle Medium with low glucose and GlutaMAXTM supplement (Gibco, #10567-014), containing 10% FBS and 1% Pen Strep. .. All cell lines were incubated in 5% CO2 at 37 ◦C and passaged periodically using 0.05% Trypsin-EDTA (Gibco, #25300-054) and centrifugation at 1000× g for 5 min.

    Article Title: N-acetyl-L-leucyl-l-lysine peptide coating for improved biofunctionality of nitinol-based medical implants
    Article Snippet: Metal implants have been functionalized with cell-derived materials, including cell-surface components, exosomes, and extracellular matrices, as well as purified proteins and other biologics such as peptides and aptamers.. However, the production costs of cell-derived materials and the limited stability of some coating materials at room temperature remain important challenges.. Here, this study developed a highly stable, ultrashort dipeptide, N-acetyl-L-leucyl-Llysine (Ac-LK), as a direct coating for the functionalization of nitinol-based implants.

    Modification:

    Article Title: High-Resolution 3D Bioprinted Hydrogel Scaffolds Enable Sustained Intraperitoneal Cell Delivery.
    Article Snippet: Gibco), hereby referred to as standard culture medium. .. Adipose-derived human mesenchymal stem cells (hMSC, PCS-500-011) were purchased from ATCC (Manassas, VA, USA). hMSC cells were cultured in Dulbecco’s Modified Eagle Medium with low glucose and GlutaMAXTM supplement (Gibco, #10567-014), containing 10% FBS and 1% Pen Strep. .. All cell lines were incubated in 5% CO2 at 37 ◦C and passaged periodically using 0.05% Trypsin-EDTA (Gibco, #25300-054) and centrifugation at 1000× g for 5 min.



    Similar Products

    human adipose derived mesenchymal stem cells asc  (ATCC)
    96
    ATCC human adipose derived mesenchymal stem cells asc
    Human Adipose Derived Mesenchymal Stem Cells Asc, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/normal+human+asc/Adipose-Derived+Mesenchymal+Stem+Cells%3B+Normal%2C+Human/pmc12122589-34-0-10
    Average 96 stars, based on 1 article reviews
    human adipose derived mesenchymal stem cells asc - by Bioz Stars, 2026-11
    96/100 stars
    		  Buy from Supplier
    normal human ascs  (ATCC)
    96
    ATCC normal human ascs
    <t>Human</t> <t>ASC</t> osteogenesis is supported by culture on SBG-PLGA composites and rhBMP-2 treatment. mRNA levels of the early and late osteoblastic markers, BMP-2 and Noggin ( NOG ) in human <t>ASCs</t> cultured on SBG-PLGA composites in ( A ), ( C ) standard osteogenic medium or ( B ), ( D ) standard osteogenic medium supplemented with 100 ng/ml rhBMP-2. Results are presented as relative mRNA expression levels vs. mRNA levels for ASCs cultured on a plain PLGA control (black line at 1). ( E ) Nitric oxide (NO) concentration in culture media after 24-h culture of ASC cells on SBG-PLGA composites in standard osteogenic medium. Averages ± SD are indicated. One-way or two-way ANOVA tests, * p < 0.05, ** p < 0.001, *** p < 0.0001 relative to the PLGA control group
    Normal Human Ascs, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/normal+human+asc/Adipose-Derived+Mesenchymal+Stem+Cells%3B+Normal%2C+Human/pmc11908086-263-6-9
    Average 96 stars, based on 1 article reviews
    normal human ascs - by Bioz Stars, 2026-11
    96/100 stars
    		  Buy from Supplier
    normal human asc  (ATCC)
    96
    ATCC normal human asc
    Figure 1. Noggin protein increases alkaline phosphatase (ALP) activity and early osteogenic genes expression in adult human mesenchymal stem cells from different tissues. Alkaline phosphatase (ALP) activity after 7-d culture of (a) normal human bone marrow stromal cells (BMSCs), (b) normal human dental pulp stem cells (DPSCs) and (c) human immortalized adipose-derived stem cell <t>line</t> <t>(ASC52telo).</t> Cells were treated with either 100 ng/ml recombinant human Noggin (NOG) or 100 ng/ml recombinant human bone morphogenetic protein 2 (BMP-2), or both (BMP-2 + NOG), in osteogenic medium containing ascorbic acid <t>(Asc)</t> and dexamethasone (Dex). (d) ALP activity after 7-d culture of ASC52telo cells in osteogenic medium with different Noggin doses (100–400 ng/ml). (a–d) Control represents cells maintained in standard growth medium. Relative mRNA levels (qPCR) of selected osteoblastic markers in (e) normal human ASCs and (f) normal human BMSCs continuously treated with Noggin (NOG) or BMP-2 for 7 days in osteogenic medium. Relative quantification to control cells cultured in osteogenic medium. (a–f) Average values ± SD are plotted. One-way ANOVA tests, *p < 0.05, **p < 0.001, ***p < 0.0001, ns—not significant, relative to respective control or between marked groups.
    Normal Human Asc, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/normal+human+asc/Adipose-Derived+Mesenchymal+Stem+Cells%3B+Normal%2C+Human/pm38509118-244-6-9
    Average 96 stars, based on 1 article reviews
    normal human asc - by Bioz Stars, 2026-11
    96/100 stars
    		  Buy from Supplier
    mesenchymal stem cells asc  (ATCC)
    96
    ATCC mesenchymal stem cells asc
    Figure 1. Noggin protein increases alkaline phosphatase (ALP) activity and early osteogenic genes expression in adult human mesenchymal stem cells from different tissues. Alkaline phosphatase (ALP) activity after 7-d culture of (a) normal human bone marrow stromal cells (BMSCs), (b) normal human dental pulp stem cells (DPSCs) and (c) human immortalized adipose-derived stem cell <t>line</t> <t>(ASC52telo).</t> Cells were treated with either 100 ng/ml recombinant human Noggin (NOG) or 100 ng/ml recombinant human bone morphogenetic protein 2 (BMP-2), or both (BMP-2 + NOG), in osteogenic medium containing ascorbic acid <t>(Asc)</t> and dexamethasone (Dex). (d) ALP activity after 7-d culture of ASC52telo cells in osteogenic medium with different Noggin doses (100–400 ng/ml). (a–d) Control represents cells maintained in standard growth medium. Relative mRNA levels (qPCR) of selected osteoblastic markers in (e) normal human ASCs and (f) normal human BMSCs continuously treated with Noggin (NOG) or BMP-2 for 7 days in osteogenic medium. Relative quantification to control cells cultured in osteogenic medium. (a–f) Average values ± SD are plotted. One-way ANOVA tests, *p < 0.05, **p < 0.001, ***p < 0.0001, ns—not significant, relative to respective control or between marked groups.
    Mesenchymal Stem Cells Asc, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/normal+human+asc/Adipose-Derived+Mesenchymal+Stem+Cells%3B+Normal%2C+Human/pm36626752-176-1-5
    Average 96 stars, based on 1 article reviews
    mesenchymal stem cells asc - by Bioz Stars, 2026-11
    96/100 stars
    		  Buy from Supplier
    human ascs  (ATCC)
    96
    ATCC human ascs
    Figure 1. Noggin protein increases alkaline phosphatase (ALP) activity and early osteogenic genes expression in adult human mesenchymal stem cells from different tissues. Alkaline phosphatase (ALP) activity after 7-d culture of (a) normal human bone marrow stromal cells (BMSCs), (b) normal human dental pulp stem cells (DPSCs) and (c) human immortalized adipose-derived stem cell <t>line</t> <t>(ASC52telo).</t> Cells were treated with either 100 ng/ml recombinant human Noggin (NOG) or 100 ng/ml recombinant human bone morphogenetic protein 2 (BMP-2), or both (BMP-2 + NOG), in osteogenic medium containing ascorbic acid <t>(Asc)</t> and dexamethasone (Dex). (d) ALP activity after 7-d culture of ASC52telo cells in osteogenic medium with different Noggin doses (100–400 ng/ml). (a–d) Control represents cells maintained in standard growth medium. Relative mRNA levels (qPCR) of selected osteoblastic markers in (e) normal human ASCs and (f) normal human BMSCs continuously treated with Noggin (NOG) or BMP-2 for 7 days in osteogenic medium. Relative quantification to control cells cultured in osteogenic medium. (a–f) Average values ± SD are plotted. One-way ANOVA tests, *p < 0.05, **p < 0.001, ***p < 0.0001, ns—not significant, relative to respective control or between marked groups.
    Human Ascs, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/normal+human+asc/Adipose-Derived+Mesenchymal+Stem+Cells%3B+Normal%2C+Human/pm32500640-315-4-6
    Average 96 stars, based on 1 article reviews
    human ascs - by Bioz Stars, 2026-11
    96/100 stars
    		  Buy from Supplier
    adipose stem cells ascs  (ATCC)
    95
    ATCC adipose stem cells ascs
    Figure 1. Noggin protein increases alkaline phosphatase (ALP) activity and early osteogenic genes expression in adult human mesenchymal stem cells from different tissues. Alkaline phosphatase (ALP) activity after 7-d culture of (a) normal human bone marrow stromal cells (BMSCs), (b) normal human dental pulp stem cells (DPSCs) and (c) human immortalized adipose-derived stem cell <t>line</t> <t>(ASC52telo).</t> Cells were treated with either 100 ng/ml recombinant human Noggin (NOG) or 100 ng/ml recombinant human bone morphogenetic protein 2 (BMP-2), or both (BMP-2 + NOG), in osteogenic medium containing ascorbic acid <t>(Asc)</t> and dexamethasone (Dex). (d) ALP activity after 7-d culture of ASC52telo cells in osteogenic medium with different Noggin doses (100–400 ng/ml). (a–d) Control represents cells maintained in standard growth medium. Relative mRNA levels (qPCR) of selected osteoblastic markers in (e) normal human ASCs and (f) normal human BMSCs continuously treated with Noggin (NOG) or BMP-2 for 7 days in osteogenic medium. Relative quantification to control cells cultured in osteogenic medium. (a–f) Average values ± SD are plotted. One-way ANOVA tests, *p < 0.05, **p < 0.001, ***p < 0.0001, ns—not significant, relative to respective control or between marked groups.
    Adipose Stem Cells Ascs, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/normal+human+asc/Adipose-Derived+Mesenchymal+Stem+Cells%3B+Normal%2C+Human/pmc08184808-8-10-17
    Average 95 stars, based on 1 article reviews
    adipose stem cells ascs - by Bioz Stars, 2026-11
    95/100 stars
    		  Buy from Supplier
    human ascs atcc pcs 500 011 tm  (ATCC)
    95
    ATCC human ascs atcc pcs 500 011 tm
    Figure 1. Noggin protein increases alkaline phosphatase (ALP) activity and early osteogenic genes expression in adult human mesenchymal stem cells from different tissues. Alkaline phosphatase (ALP) activity after 7-d culture of (a) normal human bone marrow stromal cells (BMSCs), (b) normal human dental pulp stem cells (DPSCs) and (c) human immortalized adipose-derived stem cell <t>line</t> <t>(ASC52telo).</t> Cells were treated with either 100 ng/ml recombinant human Noggin (NOG) or 100 ng/ml recombinant human bone morphogenetic protein 2 (BMP-2), or both (BMP-2 + NOG), in osteogenic medium containing ascorbic acid <t>(Asc)</t> and dexamethasone (Dex). (d) ALP activity after 7-d culture of ASC52telo cells in osteogenic medium with different Noggin doses (100–400 ng/ml). (a–d) Control represents cells maintained in standard growth medium. Relative mRNA levels (qPCR) of selected osteoblastic markers in (e) normal human ASCs and (f) normal human BMSCs continuously treated with Noggin (NOG) or BMP-2 for 7 days in osteogenic medium. Relative quantification to control cells cultured in osteogenic medium. (a–f) Average values ± SD are plotted. One-way ANOVA tests, *p < 0.05, **p < 0.001, ***p < 0.0001, ns—not significant, relative to respective control or between marked groups.
    Human Ascs Atcc Pcs 500 011 Tm, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/normal+human+asc/Adipose-Derived+Mesenchymal+Stem+Cells%3B+Normal%2C+Human/pm33039596-75-15-17
    Average 95 stars, based on 1 article reviews
    human ascs atcc pcs 500 011 tm - by Bioz Stars, 2026-11
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Human ASC osteogenesis is supported by culture on SBG-PLGA composites and rhBMP-2 treatment. mRNA levels of the early and late osteoblastic markers, BMP-2 and Noggin ( NOG ) in human ASCs cultured on SBG-PLGA composites in ( A ), ( C ) standard osteogenic medium or ( B ), ( D ) standard osteogenic medium supplemented with 100 ng/ml rhBMP-2. Results are presented as relative mRNA expression levels vs. mRNA levels for ASCs cultured on a plain PLGA control (black line at 1). ( E ) Nitric oxide (NO) concentration in culture media after 24-h culture of ASC cells on SBG-PLGA composites in standard osteogenic medium. Averages ± SD are indicated. One-way or two-way ANOVA tests, * p < 0.05, ** p < 0.001, *** p < 0.0001 relative to the PLGA control group

    Journal: Journal of Biological Engineering

    Article Title: Rapid osteoinduction of human adipose-derived stem cells grown on bioactive surfaces and stimulated by chemically modified media flow

    doi: 10.1186/s13036-025-00491-2

    Figure Lengend Snippet: Human ASC osteogenesis is supported by culture on SBG-PLGA composites and rhBMP-2 treatment. mRNA levels of the early and late osteoblastic markers, BMP-2 and Noggin ( NOG ) in human ASCs cultured on SBG-PLGA composites in ( A ), ( C ) standard osteogenic medium or ( B ), ( D ) standard osteogenic medium supplemented with 100 ng/ml rhBMP-2. Results are presented as relative mRNA expression levels vs. mRNA levels for ASCs cultured on a plain PLGA control (black line at 1). ( E ) Nitric oxide (NO) concentration in culture media after 24-h culture of ASC cells on SBG-PLGA composites in standard osteogenic medium. Averages ± SD are indicated. One-way or two-way ANOVA tests, * p < 0.05, ** p < 0.001, *** p < 0.0001 relative to the PLGA control group

    Article Snippet: ASC52telo cells (ASC; ATCC, SCRC-4000) and normal human ASCs (ATCC, PCS-500-011) were expanded in the dedicated medium (ATCC, Mesenchymal Stem Cell Basal Medium with Mesenchymal Stem Cell Growth Kit and G418).

    Techniques: Cell Culture, Expressing, Control, Concentration Assay

    Cumulative osteogenic effect of Phenamil and PD98059 treatment in rhBMP-2 stimulated human ASCs cultured on SBG-PLGA composites. mRNA levels of osteoblastic markers in ( A ) 7-day and ( B ) 21-day ASC cultures on SBG-PLGA composites. ASCs were cultured in osteogenic medium supplemented with 100 ng/ml rhBMP-2 or 100 ng/ml rhBMP-2, 50 µM PD98059 and 20 µM Phenamil. Results are presented as relative mRNA expression compared to mRNA levels in control cells cultured on PLGA with rhBMP-2 only (marked as black line at 1). ( C ) mRNA levels of selected osteoblastic markers in 3-day osteogenic ASC cultures treated with different doses of rhBMP-2 (25–250 ng/ml), Phenamil (5–50 µM) or PD98059 (1-125 µM); under fluid shear stress. Results are presented as the expression relative to osteogenic cultures treated only with ascorbic acid, dexamethasone and β-glycerophosphate. ( D ) Graphical hypothesis of BMP-2, PD98059 and Phenamil cross-talk in intracellular signaling. Average values ± SD are indicated. Two-way ANOVA test, * p < 0.05, ** p < 0.001, *** p < 0.0001 relative to the PLGA control group or between marked groups. BMP-2 – bone morphogenetic protein 2, OC – osteocalcin, ON – osteonectin, FOS – AP-1 transcription factor subunit (c-fos), OPG – osteoprotegerin

    Journal: Journal of Biological Engineering

    Article Title: Rapid osteoinduction of human adipose-derived stem cells grown on bioactive surfaces and stimulated by chemically modified media flow

    doi: 10.1186/s13036-025-00491-2

    Figure Lengend Snippet: Cumulative osteogenic effect of Phenamil and PD98059 treatment in rhBMP-2 stimulated human ASCs cultured on SBG-PLGA composites. mRNA levels of osteoblastic markers in ( A ) 7-day and ( B ) 21-day ASC cultures on SBG-PLGA composites. ASCs were cultured in osteogenic medium supplemented with 100 ng/ml rhBMP-2 or 100 ng/ml rhBMP-2, 50 µM PD98059 and 20 µM Phenamil. Results are presented as relative mRNA expression compared to mRNA levels in control cells cultured on PLGA with rhBMP-2 only (marked as black line at 1). ( C ) mRNA levels of selected osteoblastic markers in 3-day osteogenic ASC cultures treated with different doses of rhBMP-2 (25–250 ng/ml), Phenamil (5–50 µM) or PD98059 (1-125 µM); under fluid shear stress. Results are presented as the expression relative to osteogenic cultures treated only with ascorbic acid, dexamethasone and β-glycerophosphate. ( D ) Graphical hypothesis of BMP-2, PD98059 and Phenamil cross-talk in intracellular signaling. Average values ± SD are indicated. Two-way ANOVA test, * p < 0.05, ** p < 0.001, *** p < 0.0001 relative to the PLGA control group or between marked groups. BMP-2 – bone morphogenetic protein 2, OC – osteocalcin, ON – osteonectin, FOS – AP-1 transcription factor subunit (c-fos), OPG – osteoprotegerin

    Article Snippet: ASC52telo cells (ASC; ATCC, SCRC-4000) and normal human ASCs (ATCC, PCS-500-011) were expanded in the dedicated medium (ATCC, Mesenchymal Stem Cell Basal Medium with Mesenchymal Stem Cell Growth Kit and G418).

    Techniques: Cell Culture, Expressing, Control, Shear

    Fluid shear stress strengthens the osteogenic effects of rhBMP-2, PD98059 and Phenamil in ASCs cultured on SBG-PLGA composites. mRNA levels of osteoblastic markers after 7-day ASC culture on SBG-PLGA composites in ( A ) standard osteogenic medium under either static conditions or with fluid shear stress; and ( C ) osteogenic medium supplemented with 100 ng/ml rhBMP-2, 50 µM PD98059 and 20 µM Phenamil under either static conditions or with fluid shear stress. Results are presented as relative mRNA expression levels compared to mRNA levels in a control, static culture on PLGA (marked as a black line at 1). ( B ) The method of fluid shear stress application in ASC cultures using a standard laboratory see-saw rocker (7° tilt angle, 6 RPM frequency). ( D ) F-actin distribution in ASCs (Phalloidin-Atto488, magenta colored) at day 3 of culture in osteogenic medium supplemented with rhBMP-2, PD98059 and Phenamil after continuous static or dynamic culture conditions applied for 3 days. Scale bar represents 100 μm. ( E ) Western blot (WB) analysis of p-ERK1/2 and p-SMAD1/5/8 in ASCs after 1-h treatment with rhBMP-2 or rhBMP-2, PD98059 and Phenamil in static or dynamic conditions (upper panel) along with densitometric quantifications of WB results normalized to GAPDH levels. Averages ± SD are indicated. Two-way ANOVA test, * p < 0.05, ** p < 0.001, *** p < 0.0001 relative to the static PLGA control or between marked groups

    Journal: Journal of Biological Engineering

    Article Title: Rapid osteoinduction of human adipose-derived stem cells grown on bioactive surfaces and stimulated by chemically modified media flow

    doi: 10.1186/s13036-025-00491-2

    Figure Lengend Snippet: Fluid shear stress strengthens the osteogenic effects of rhBMP-2, PD98059 and Phenamil in ASCs cultured on SBG-PLGA composites. mRNA levels of osteoblastic markers after 7-day ASC culture on SBG-PLGA composites in ( A ) standard osteogenic medium under either static conditions or with fluid shear stress; and ( C ) osteogenic medium supplemented with 100 ng/ml rhBMP-2, 50 µM PD98059 and 20 µM Phenamil under either static conditions or with fluid shear stress. Results are presented as relative mRNA expression levels compared to mRNA levels in a control, static culture on PLGA (marked as a black line at 1). ( B ) The method of fluid shear stress application in ASC cultures using a standard laboratory see-saw rocker (7° tilt angle, 6 RPM frequency). ( D ) F-actin distribution in ASCs (Phalloidin-Atto488, magenta colored) at day 3 of culture in osteogenic medium supplemented with rhBMP-2, PD98059 and Phenamil after continuous static or dynamic culture conditions applied for 3 days. Scale bar represents 100 μm. ( E ) Western blot (WB) analysis of p-ERK1/2 and p-SMAD1/5/8 in ASCs after 1-h treatment with rhBMP-2 or rhBMP-2, PD98059 and Phenamil in static or dynamic conditions (upper panel) along with densitometric quantifications of WB results normalized to GAPDH levels. Averages ± SD are indicated. Two-way ANOVA test, * p < 0.05, ** p < 0.001, *** p < 0.0001 relative to the static PLGA control or between marked groups

    Article Snippet: ASC52telo cells (ASC; ATCC, SCRC-4000) and normal human ASCs (ATCC, PCS-500-011) were expanded in the dedicated medium (ATCC, Mesenchymal Stem Cell Basal Medium with Mesenchymal Stem Cell Growth Kit and G418).

    Techniques: Shear, Cell Culture, Expressing, Control, Western Blot

    Zinc (ZnO) or strontium (SrO) modified SBG-PLGA composites combined with fluid shear stress and BMP-based chemical stimulation, further increase osteogenic markers expression in early ASC cultures. mRNA levels of osteoblastic markers in ( A ) 3-day and ( B ) 6-day osteogenic ASC cultures on PLGA-based composites containing either unmodified or SrO- or ZnO-modified SBGs. Cells were treated with a combination of rhBMP-2, PD98059 and Phenamil at the indicated culture times in either static cultures or under fluid shear stress. Upper panels show the schemes of the ASC treatments. Results are presented as relative mRNA expression levels vs. mRNA levels in a control, static culture on PLGA (marked as a black line at 1). ( C ) Western blot (WB) analysis of phospho-β-catenin(Ser552), COX-2 and phospho-CREB(Ser133) levels in ASCs after 1-h treatment with rhBMP-2 or rhBMP-2, PD98059 and Phenamil in static or dynamic conditions (left panel) along with densitometric quantifications of WB results normalized to GAPDH levels (right panel). ( D ) Hypothesized signaling pathways involved in osteogenic response to treatment strategy. Averages ± SD are indicated. Two-way ANOVA test, * p < 0.05, ** p < 0.001, *** p < 0.0001 relative to the respective static PLGA control group or between marked groups

    Journal: Journal of Biological Engineering

    Article Title: Rapid osteoinduction of human adipose-derived stem cells grown on bioactive surfaces and stimulated by chemically modified media flow

    doi: 10.1186/s13036-025-00491-2

    Figure Lengend Snippet: Zinc (ZnO) or strontium (SrO) modified SBG-PLGA composites combined with fluid shear stress and BMP-based chemical stimulation, further increase osteogenic markers expression in early ASC cultures. mRNA levels of osteoblastic markers in ( A ) 3-day and ( B ) 6-day osteogenic ASC cultures on PLGA-based composites containing either unmodified or SrO- or ZnO-modified SBGs. Cells were treated with a combination of rhBMP-2, PD98059 and Phenamil at the indicated culture times in either static cultures or under fluid shear stress. Upper panels show the schemes of the ASC treatments. Results are presented as relative mRNA expression levels vs. mRNA levels in a control, static culture on PLGA (marked as a black line at 1). ( C ) Western blot (WB) analysis of phospho-β-catenin(Ser552), COX-2 and phospho-CREB(Ser133) levels in ASCs after 1-h treatment with rhBMP-2 or rhBMP-2, PD98059 and Phenamil in static or dynamic conditions (left panel) along with densitometric quantifications of WB results normalized to GAPDH levels (right panel). ( D ) Hypothesized signaling pathways involved in osteogenic response to treatment strategy. Averages ± SD are indicated. Two-way ANOVA test, * p < 0.05, ** p < 0.001, *** p < 0.0001 relative to the respective static PLGA control group or between marked groups

    Article Snippet: ASC52telo cells (ASC; ATCC, SCRC-4000) and normal human ASCs (ATCC, PCS-500-011) were expanded in the dedicated medium (ATCC, Mesenchymal Stem Cell Basal Medium with Mesenchymal Stem Cell Growth Kit and G418).

    Techniques: Modification, Shear, Expressing, Control, Western Blot, Protein-Protein interactions

    Figure 1. Noggin protein increases alkaline phosphatase (ALP) activity and early osteogenic genes expression in adult human mesenchymal stem cells from different tissues. Alkaline phosphatase (ALP) activity after 7-d culture of (a) normal human bone marrow stromal cells (BMSCs), (b) normal human dental pulp stem cells (DPSCs) and (c) human immortalized adipose-derived stem cell line (ASC52telo). Cells were treated with either 100 ng/ml recombinant human Noggin (NOG) or 100 ng/ml recombinant human bone morphogenetic protein 2 (BMP-2), or both (BMP-2 + NOG), in osteogenic medium containing ascorbic acid (Asc) and dexamethasone (Dex). (d) ALP activity after 7-d culture of ASC52telo cells in osteogenic medium with different Noggin doses (100–400 ng/ml). (a–d) Control represents cells maintained in standard growth medium. Relative mRNA levels (qPCR) of selected osteoblastic markers in (e) normal human ASCs and (f) normal human BMSCs continuously treated with Noggin (NOG) or BMP-2 for 7 days in osteogenic medium. Relative quantification to control cells cultured in osteogenic medium. (a–f) Average values ± SD are plotted. One-way ANOVA tests, *p < 0.05, **p < 0.001, ***p < 0.0001, ns—not significant, relative to respective control or between marked groups.

    Journal: Scientific reports

    Article Title: Noggin promotes osteogenesis in human adipose-derived mesenchymal stem cells via FGFR2/Src/Akt and ERK signaling pathway.

    doi: 10.1038/s41598-024-56858-w

    Figure Lengend Snippet: Figure 1. Noggin protein increases alkaline phosphatase (ALP) activity and early osteogenic genes expression in adult human mesenchymal stem cells from different tissues. Alkaline phosphatase (ALP) activity after 7-d culture of (a) normal human bone marrow stromal cells (BMSCs), (b) normal human dental pulp stem cells (DPSCs) and (c) human immortalized adipose-derived stem cell line (ASC52telo). Cells were treated with either 100 ng/ml recombinant human Noggin (NOG) or 100 ng/ml recombinant human bone morphogenetic protein 2 (BMP-2), or both (BMP-2 + NOG), in osteogenic medium containing ascorbic acid (Asc) and dexamethasone (Dex). (d) ALP activity after 7-d culture of ASC52telo cells in osteogenic medium with different Noggin doses (100–400 ng/ml). (a–d) Control represents cells maintained in standard growth medium. Relative mRNA levels (qPCR) of selected osteoblastic markers in (e) normal human ASCs and (f) normal human BMSCs continuously treated with Noggin (NOG) or BMP-2 for 7 days in osteogenic medium. Relative quantification to control cells cultured in osteogenic medium. (a–f) Average values ± SD are plotted. One-way ANOVA tests, *p < 0.05, **p < 0.001, ***p < 0.0001, ns—not significant, relative to respective control or between marked groups.

    Article Snippet: ASC52telo cells (ASC; ATCC, SCRC-4000) and normal human ASC (ATCC, PCS-500-011) were expanded in the dedicated medium (ATCC, Mesenchymal Stem Cell Basal Medium with Mesenchymal Stem Cell Growth Kit).

    Techniques: Activity Assay, Expressing, Derivative Assay, Recombinant, Control, Quantitative Proteomics, Cell Culture

    Figure 7. The suggested new signaling pathways induced by Noggin in human ASC osteogenic cultures. We have demonstrated that Noggin can activate FGFR2 receptors and Src kinase associated with the receptor complex. This results in ERK1/2 phosphorylation and, independently of PI3k, Akt kinase phosphorylation. It is known that dexamethasone, a component of osteogenic medium, stimulates RUNX2 and TAZ expressions. We have shown Noggin activation of Akt that leads to blocking the ability of GSK3 to degrade TAZ and suppress RUNX2 activity, thereby stabilizing TAZ and enhancing formation of RUNX2-TAZ complexes. Whereas RUNX2-TAZ complexes can be phosphorylated by Noggin-activated ERK1/2. Such activated RUNX2-TAZ complexes are required for the transcription of osteogenic genes. Besides, we have shown Noggin-related inhibition of SMAD1/5/8 activity, which may be a result of increased SMAD 7 expression due to Akt activity. Figure was created in Affinity Designer software (1.10.6).

    Journal: Scientific reports

    Article Title: Noggin promotes osteogenesis in human adipose-derived mesenchymal stem cells via FGFR2/Src/Akt and ERK signaling pathway.

    doi: 10.1038/s41598-024-56858-w

    Figure Lengend Snippet: Figure 7. The suggested new signaling pathways induced by Noggin in human ASC osteogenic cultures. We have demonstrated that Noggin can activate FGFR2 receptors and Src kinase associated with the receptor complex. This results in ERK1/2 phosphorylation and, independently of PI3k, Akt kinase phosphorylation. It is known that dexamethasone, a component of osteogenic medium, stimulates RUNX2 and TAZ expressions. We have shown Noggin activation of Akt that leads to blocking the ability of GSK3 to degrade TAZ and suppress RUNX2 activity, thereby stabilizing TAZ and enhancing formation of RUNX2-TAZ complexes. Whereas RUNX2-TAZ complexes can be phosphorylated by Noggin-activated ERK1/2. Such activated RUNX2-TAZ complexes are required for the transcription of osteogenic genes. Besides, we have shown Noggin-related inhibition of SMAD1/5/8 activity, which may be a result of increased SMAD 7 expression due to Akt activity. Figure was created in Affinity Designer software (1.10.6).

    Article Snippet: ASC52telo cells (ASC; ATCC, SCRC-4000) and normal human ASC (ATCC, PCS-500-011) were expanded in the dedicated medium (ATCC, Mesenchymal Stem Cell Basal Medium with Mesenchymal Stem Cell Growth Kit).

    Techniques: Protein-Protein interactions, Phospho-proteomics, Activation Assay, Blocking Assay, Activity Assay, Inhibition, Expressing, Software